Literature DB >> 8385449

Retinoic acid and craniofacial development: molecules and morphogenesis.

G Morriss-Kay1.   

Abstract

Retinoic acid (RA), a derivative of vitamin A, is essential for normal mammalian development. Developmental abnormalities induced by RA excess and vitamin A deficiency are different even though they affect the same organ systems, and it is clear that there are intraembryonic tissue differences in the requirement for RA. The developmental functions of RA are mediated by its effects on gene expression. In the nucleus, two different forms of RA bind to and activate two families of nuclear receptors, which themselves co-operate in initiating the transcription of target genes. In this article I propose that the amount of RA reaching the nucleus in different embryonic tissues is modulated by a mechanism involving three cytoplasmic binding proteins for retinol (CRBP I) and retinoic acid (CRABP I and II). Abnormalities of craniofacial development resulting from exposure of early neural plate stage embryos to RA excess have been studied in some detail; their initial stages involve alteration of both morphological development and the segment-specific pattern of gene expression in the early hindbrain and its derived neural crest. This system is ideal for studying the relationships between retinoic acid receptors, retinoid binding proteins, and the development of genetic and morphological pattern.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8385449     DOI: 10.1002/bies.950150103

Source DB:  PubMed          Journal:  Bioessays        ISSN: 0265-9247            Impact factor:   4.345


  25 in total

1.  Segmentation in staged human embryos: the occipitocervical region revisited.

Authors:  Fabiola Müller; Ronan O'Rahilly
Journal:  J Anat       Date:  2003-09       Impact factor: 2.610

2.  Retinoic acid, GABA-ergic, and TGF-beta signaling systems are involved in human cleft palate fibroblast phenotype.

Authors:  Tiziano Baroni; Catia Bellucci; Cinzia Lilli; Furio Pezzetti; Francesco Carinci; Ennio Becchetti; Paolo Carinci; Giordano Stabellini; Mario Calvitti; Eleonora Lumare; Maria Bodo
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

3.  Significance of G-X-W motif in the myocilin olfactomedin domain.

Authors:  K Rangachari; J Jeyalaxmi; P J Eswari Pandaranayaka; N Prasanthi; P Sundaresan; S R Krishnadas; S Krishnaswamy
Journal:  J Ocul Biol Dis Infor       Date:  2012-06-05

4.  Low maternal retinol as a risk factor for schizophrenia in adult offspring.

Authors:  YuanYuan Bao; Ghionul Ibram; William S Blaner; Charles P Quesenberry; Ling Shen; Ian W McKeague; Catherine A Schaefer; Ezra S Susser; Alan S Brown
Journal:  Schizophr Res       Date:  2012-02-29       Impact factor: 4.939

Review 5.  Retinoids and binding proteins in the cerebellum during lifetime.

Authors:  Rosalba Parenti; Federico Cicirata
Journal:  Cerebellum       Date:  2004       Impact factor: 3.847

6.  High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice.

Authors:  T Lufkin; D Lohnes; M Mark; A Dierich; P Gorry; M P Gaub; M LeMeur; P Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

7.  Retinoic acid is present in the postnatal rat olfactory organ and persists in vitamin A--depleted neural tissue.

Authors:  Mary Ann Asson-Batres; W Bradford Smith; Gale Clark
Journal:  J Nutr       Date:  2009-04-29       Impact factor: 4.798

8.  Effects of retinoic acid on the neural crest-controlled organs of fetal rats.

Authors:  Jiakang Yu; Salome Gonzalez; Leopoldo Martinez; Juan A Diez-Pardo; Juan A Tovar
Journal:  Pediatr Surg Int       Date:  2003-07-24       Impact factor: 1.827

9.  Prenatal nutritional deficiency and risk of adult schizophrenia.

Authors:  Alan S Brown; Ezra S Susser
Journal:  Schizophr Bull       Date:  2008-08-04       Impact factor: 9.306

10.  Upregulation of CRABP1 in human neuroblastoma cells overproducing the Alzheimer-typical Abeta42 reduces their differentiation potential.

Authors:  Markus Uhrig; Peter Brechlin; Olaf Jahn; Yuri Knyazev; Annette Weninger; Laura Busia; Kamran Honarnejad; Markus Otto; Tobias Hartmann
Journal:  BMC Med       Date:  2008-12-16       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.